US-based biotechnology company Integral Molecular will leverage its technology platforms to identify Covid-19 vaccines and therapeutics. Shotgun Mutagenesis Epitope Mapping and the Membrane Proteome Array will be used to gain insights into the human immune […]
Kala Pharmaceuticals said that its dry eye disease candidate KPI-121 0.25% has delivered positive results in a phase 3 trial called STRIDE 3. Planned to be branded as EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25%, KPI-121 […]
Mount Sinai Health System and Harbour BioMed (HBM) have entered into a multi-year, multifaceted collaboration to develop novel, fully human antibodies for the treatment and prevention of various diseases including oncology and immunology. The collaboration […]
SMi Reports: There will be a workshop surrounding ‘Developing apps for Connected Drug Delivery’ for Injectable Drug Delivery 2020 The Injectable Drug Delivery conference will reconvene on the 13th and 14th May 2020 in London, […]
SMi Reports: An Interview with Martin Everett, Chief Scientific Officer, at Antabio, who will be speaking at SMi’s highly anticipated 22nd Annual Superbugs & Superdrugs Conference on the 30th and 31st March 2020 in London. […]